Towner K J, Slack R C
Eur J Clin Microbiol. 1986 Oct;5(5):502-6. doi: 10.1007/BF02017691.
The incidence of trimethoprim resistance was correlated with changes in prescription behaviour in the Nottingham area from 1978-1985. The prevalence of trimethoprim resistance among Enterobacteriaceae isolated from patients with urinary tract infection rose from 5% to 15% of total strains examined. Strains resistant to trimethoprim but susceptible to sulfamethoxazole appeared from 1980 onward and represented 35% of the total trimethoprim-resistant strains examined in 1985. Co-trimoxazole (trimethoprim + sulfamethoxazole) has been generally available for prescription in the United Kingdom since 1969, whereas trimethoprim alone was released in October 1979. By 1983, prescriptions in the form of trimethoprim alone accounted for approximately 50% (in hospitals) and 15% (in the community) of total trimethoprim usage in the Nottingham area. Although the introduction of trimethoprim alone seems to have had only a minor effect on overall resistance levels, it has greatly increased the proportion of trimethoprim-resistant strains which are susceptible to sulfamethoxazole. This was particularly evident in strains of Proteus spp., in which 52% of the total trimethoprim-resistant strains were sulfamethoxazole-susceptible in 1985.
1978年至1985年期间,诺丁汉地区甲氧苄啶耐药性的发生率与处方行为的变化相关。从尿路感染患者中分离出的肠杆菌科细菌对甲氧苄啶的耐药率从所检测菌株总数的5%上升至15%。对甲氧苄啶耐药但对磺胺甲恶唑敏感的菌株自1980年起出现,在1985年所检测的对甲氧苄啶耐药的菌株总数中占35%。自1969年起,复方新诺明(甲氧苄啶+磺胺甲恶唑)在英国可普遍用于处方,而甲氧苄啶单独制剂于1979年10月上市。到1983年,仅以甲氧苄啶形式开具的处方在诺丁汉地区甲氧苄啶总用量中约占50%(在医院)和15%(在社区)。尽管单独使用甲氧苄啶似乎对总体耐药水平影响较小,但它大大增加了对磺胺甲恶唑敏感的甲氧苄啶耐药菌株的比例。这在变形杆菌属菌株中尤为明显,1985年在对甲氧苄啶耐药的菌株总数中,52%对磺胺甲恶唑敏感。